“Exogenous Glutamate Oxalacetate Transaminase 1 (GOT1) as a new treatment for Amyotrophic Lateral Sclerosis (ALS): Developing preclinical study” by Lucía del Pozo Filíu Descarga o programa da xornada aquí Para seguilo de forma online podes facelo a través do link